Literature DB >> 8414993

A topoisomerase II-like protein is part of an inducible DNA-binding protein complex that binds 5' of an immunoglobulin promoter.

C F Webb1, K L Eneff, F H Drake.   

Abstract

We previously identified a B cell-specific protein-DNA complex 5' of an immunoglobulin mu heavy chain promoter. The sequences to which this protein complex bound were required for induction of immunoglobulin mRNA levels with interleukin-5 + antigen. Further studies identified a second sequence 5' of these regulatory sequences that bound to both the nuclear matrix and to a similar interleukin-5 + antigen inducible protein complex. Therefore, we sought to identify the putative regulatory proteins that comprised this DNA-binding complex. In this study, we have used anti-topoisomerase II antibodies to demonstrate that one of the proteins found in the interleukin-5 + antigen inducible complexes is serologically related to topoisomerase II. To our knowledge, this is the first report where a topoisomerase II related protein participates in an inducible mobility shifted protein-DNA complex. These data suggest a model in which the enhanced immunoglobulin gene transcription observed after treatment with interleukin-5 + antigen might be explained by the induction of a protein complex that acts to relieve torsional stress along the gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414993      PMCID: PMC310073          DOI: 10.1093/nar/21.18.4363

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes.

Authors:  C Negri; R Chiesa; A Cerino; M Bestagno; C Sala; N Zini; N M Maraldi; G C Astaldi Ricotti
Journal:  Exp Cell Res       Date:  1992-06       Impact factor: 3.905

2.  Dysfunction of chromosomal loop attachment sites: illegitimate recombination linked to matrix association regions and topoisomerase II.

Authors:  A O Sperry; V C Blasquez; W T Garrard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences.

Authors:  N F Landolfi; J D Capra; P W Tucker
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

4.  The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements.

Authors:  P N Cockerill; M H Yuen; W T Garrard
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

5.  Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

Authors:  F H Drake; J P Zimmerman; F L McCabe; H F Bartus; S R Per; D M Sullivan; W E Ross; M R Mattern; R K Johnson; S T Crooke
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

6.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

7.  A protein kinase activity tightly associated with Drosophila type II DNA topoisomerase.

Authors:  M Sander; J M Nolan; T Hsieh
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction.

Authors:  M Berrios; N Osheroff; P A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.

Authors:  B D Halligan; K A Edwards; L F Liu
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

10.  Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster.

Authors:  S M Gasser; U K Laemmli
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

View more
  6 in total

Review 1.  Structure and function of type II DNA topoisomerases.

Authors:  P M Watt; I D Hickson
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

2.  Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?

Authors:  Michael C Haffner; Angelo M De Marzo; Alan K Meeker; William G Nelson; Srinivasan Yegnasubramanian
Journal:  Clin Cancer Res       Date:  2011-03-08       Impact factor: 12.531

3.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 4.  The transcription factor, Bright, and immunoglobulin heavy chain expression.

Authors:  C F Webb
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

5.  Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.

Authors:  M K Ritke; D Roberts; W P Allan; J Raymond; V V Bergoltz; J C Yalowich
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

Review 6.  The Bright Side of Hematopoiesis: Regulatory Roles of ARID3a/Bright in Human and Mouse Hematopoiesis.

Authors:  Michelle L Ratliff; Troy D Templeton; Julie M Ward; Carol F Webb
Journal:  Front Immunol       Date:  2014-03-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.